Article
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site
21 Nov 2023
Abstract excerpt
The HIV-1 fusion peptide (FP) represents a promising vaccine target, but global FP sequence diversity among circulating strains has limited anti-FP antibodies to ~60% neutralization breadth. Here we evolve the FP-targeting antibody VRC34.01 in vitro to enhance FP-neutralization using site saturation mutagenesis and yeast display. Successive rounds of directed evolution by iterative selection of antibodies for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
